A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention | Zendy

William W. O’Neill | Zendy; Neal S. Kleiman | Zendy; Jeffrey W. Moses | Zendy; José P.S. Henriques | Zendy; Simon Dixon | Zendy; Joseph M. Massaro | Zendy; Igor F. Palacios | Zendy; Brijeshwar Maini | Zendy; Suresh Mulukutla | Zendy; Vladimír Džavík | Zendy; Jeffrey J. Popma | Zendy; Pamela S. Douglas | Zendy; Magnus Öhman | Zendy

Open Access

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Author(s) -

William W. O’Neill,

Neal S. Kleiman,

Jeffrey W. Moses,

José P.S. Henriques,

Simon Dixon,

Joseph M. Massaro,

Igor F. Palacios,

Brijeshwar Maini,

Suresh Mulukutla,

Vladimír Džavík,

Jeffrey J. Popma,

Pamela S. Douglas,

Magnus Öhman

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.112.098194

Subject(s) - medicine , impella , percutaneous coronary intervention , intra aortic balloon pump , hemodynamics , cardiology , randomized controlled trial , balloon , percutaneous , surgery , intra aortic balloon pumping , myocardial infarction , cardiogenic shock

Although coronary artery bypass grafting is generally preferred in symptomatic patients with severe, complex multivessel, or left main disease, some patients present with clinical features that make coronary artery bypass grafting clinically unattractive. Percutaneous coronary intervention with hemodynamic support may be feasible for these patients. Currently, there is no systematic comparative evaluation of hemodynamic support devices for this indication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research